Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland

The present multi-center, long-term, real-life study made an attempt to assess the efficacy of risankizumab in the treatment of moderate-to-severe plaque psoriasis. The study comprised 185 patients from 10 Polish dermatologic departments undergoing risankizumab treatment. The disease severity was me...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamczyk, Michał, Bartosińska, Joanna, Raczkiewicz, Dorota, Adamska, Kinga, Adamski, Zygmunt, Czubek, Maria, Kręcisz, Beata, Kłujszo, Elżbieta, Lesiak, Aleksandra, Narbutt, Joanna, Noweta, Marcin, Owczarczyk-Saczonek, Agnieszka, Owczarek, Witold, Reich, Adam, Samotij, Dominik, Siekierko, Aleksandra, Szczęch, Justyna, Walecka, Irena, Ciechanowicz, Piotr, Woźniacka, Anna, Liszewska, Agata, Krasowska, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959800/
https://www.ncbi.nlm.nih.gov/pubmed/36836209
http://dx.doi.org/10.3390/jcm12041675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959800/
https://www.ncbi.nlm.nih.gov/pubmed/36836209
http://dx.doi.org/10.3390/jcm12041675

Ejemplares similares